4Sandri AM, Dalarosa MG, Ruschel de Alcantara LR, et al. Reduction in incidence of nosoeomial methicillinresistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA [J]. Infect Control Hosp Epidemiol,2006,27(2): 185-187.
5Huang SS, Vokoe DS, Hinrichsen VL, et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillinresistant Staphylococcus aureus bacteremia [J]. Clin Infect Dis ,2006,43(8) :971-978.
6Richards M J, Edwards JR, Gaynes RP, et cd. Nosocomial infections in pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System [J]. Pediatrics, 1999,103(4) :e39.
7Grisara-Soen G, Sweed Y, Lerner-Geva L, et al. Nosocomial bloodstream infections in a pediatric intensive care unit: 3-year survey [J]. Med Sci Monit,2007,13 (6) :CR251-257.
8Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guiderline for preventing nosocomial transmission of muhidrug-resistant strains of Staphylococcus aureus and enterocoecus [J ]. Infect Control Hosp Epidemiol,2003,24 (5) :362-381.
9Clark RH,Thomas P,Peabody J.Extrautsrine growth restriction remains a serious problem in prematurely born neonates.Pediatrics,2003,111:986-990.
10Uhing MR,Das UG.Optimizing growth in the preterm infant.Clin Perinatol,2009,36:165-176.
